Thailand HIV and Stigma Reduction Study
ConditionPre-Exposure Prophylaxis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18-29
SponsorUniversity of Massachusetts, Worcester
About this trial
This project will develop a multi-component, technology-delivered intervention designed to reduce HIV and intersectional stigma and improve the use of HIV pre-exposure prophylaxis (PrEP) among HIV-negative Thai vulnerable emerging adults (18-29 years).
Eligibility criteria
Qualifiers
Ages between 18 and 29 years
Male sex at birth
Self-identifies as women, transgender women or culturally identifies with the female spectrum
Laboratory-confirmed HIV-negative status
Disqualifiers
Have a serious cognitive or psychiatric problem compromising ability to provide informed consent
Have active suicidal ideation or major mental illness at the time of interview (these patients will be referred for treatment)
Laboratory or clinical findings that would preclude PrEP initiation (e.g., decreased creatinine clearance)
Currently enrolled in another HIV intervention study.
Trial design
Treatments tested in this trial
- Mobile Healthy Choices (mHC)
- Finding Respect and Ending Stigma around HIV (FRESH)
- Standard PrEP Counseling
Treatment groups
154 Participants
are divided into 4 treatment groupsSponsors and collaborators
University of Massachusetts, Worcester
Lead sponsor
National Institute of Mental Health (NIMH)
Collaborator
Institute of HIV Research and Innovation Foundation, Thailand
Collaborator
Source ClinicalTrials.gov